Business Wire

SoftServe Expands Partnership with Google Cloud for Launch of New Manufacturing Solutions

26.5.2022 16:05:00 EEST | Business Wire | Press release

Share

SoftServe, a leading digital authority and consulting company, has been unveiled as a services partner of two new Google Cloud manufacturing solutions. The solutions—Manufacturing Data Engine and Manufacturing Connect—were announced earlier this month at the virtual Google Cloud Manufacturing Spotlight Event and are positioned to accelerate and scale digital transformation projects in the manufacturing sector.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220526005027/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

SoftServe Expands Partnership with Google Cloud for Launch of New Manufacturing Solutions (Graphic: Business Wire)

In partnership with Google Cloud, SoftServe provided valuable feedback in the development of the solutions, from early-stage implementation to launch. Manufacturing Data Engine is an end-to-end solution that processes, contextualizes, and stores factory data on Google Cloud’s market-leading data platform, providing a blueprint for the data. Manufacturing Connect is a factory edge platform, co-developed with Litmus Automation, that quickly connects to, and streams data from, any manufacturing asset and industrial system to Google Cloud.

“As a solutions-focused company, we are very proud to partner with Google Cloud and bring cutting-edge technology to our clients across the manufacturing sector,” said Volodymyr Semenyshyn, President, EMEA at SoftServe. “Our portfolio of partners is strong and strategic, and this partnership with Google Cloud allows us to leverage our expertise in Big Data and Artificial Intelligence to deliver high value solutions to our manufacturing clients.”

Global competition and fast-paced demand patterns are top challenges for manufacturers today. SoftServe’ provided input for the development of the Manufacturing Data Engine and Manufacturing Connect from Google Cloud, the solutions that allow manufacturers to create industry-grade solutions rooted in Big Data and Artificial Intelligence to reduce downtime and optimize performance. In contrast to many pre-existing solutions, the new Google Cloud solutions bring key capabilities directly to engineers, enabling them to combine insights with deep domain expertise, leading to better results and achievement of objectives.

SoftServe is a Google Cloud Partner with deep and recognized expertise in leveraging Artificial Intelligence, Machine Learning, and Data Analytics for customers. SoftServe has been awarded five Google specializations, in addition to the 2020 Google Cloud Global Specialization Partner of the Year – Machine Learning.

To learn more about SoftServe’s partnership with Google Cloud and the launch of these innovative solutions, visit the partnership website.

About SoftServe

Employing more than 13,000 associates in 41 centers, offices, and client locations globally, SoftServe has a proven track record in healthcare and life sciences, financial services, retail, high-tech (ISVs), manufacturing, and energy industries. The company offers deep expertise across software engineering, cloud and DevOps, big data and analytics, artificial intelligence and machine learning, the Internet of Things, experience design and platforms, extended reality (XR) and robotics.

SoftServe delivers open innovation—from generating compelling new ideas, to developing and implementing transformational products and services. Our work and client experience are built on a foundation of empathetic, human-focused experience design that ensures continuity from concept to release. We empower enterprises and software companies to (re)identify differentiation, accelerate solution development, and vigorously compete in today’s digital economy.

Visit our website, blog, LinkedIn, Facebook, and Twitter pages.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Andrew Kavka
Analyst and Public Relations Lead
akavk@softserveinc.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

euNetworks launches new quantum-safe private connectivity service powered by Adtran’s encrypted optical transport technology27.5.2026 11:00:00 EEST | Press release

Adtran and euNetworks today announced their collaboration on the launch of a new quantum-safe private connectivity service, Quantum Shield. euNetworks has developed Quantum Shield using Adtran’s optical transport technology to augment its broader architecture, which is designed to deliver secure, scalable data center connectivity across euNetworks’ pan-European network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526610601/en/ Adtran’s encrypted optical transport technology is helping euNetworks deliver the highest levels of protection for sensitive data moving across Europe. The new offering is built for enterprises with stringent security, performance and customer-controlled encryption requirements. The deployment combines high-capacity dedicated infrastructure with real-time fiber monitoring and enhanced optical-layer visibility to safeguard critical traffic. By integrating advanced encryption with continuous monito

National Bank of Greece in Cyprus Goes Live With Smartstream’s Air to Consolidate Reconciliations27.5.2026 10:55:00 EEST | Press release

Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces that the National Bank of Greece (NBG) in Cyprus has successfully gone live with Air, the company’s AI-enabled reconciliation solution. The go-live marks a significant step forward in the bank’s operational efficiency, reducing daily manual processing effort and eliminating the complexity of working across multiple data formats. The bank has deployed Air’s Cash module, replacing both incumbent and consolidating four separate reconciliation systems for Instant, Cash, SEPA, and Nostro reconciliations, into a single, intelligent platform. Although transaction volumes were manageable, the fragmented landscape required significant daily manual effort to handle items individually across each system and to navigate multiple data formats. Following a market review, the bank committed to Smartstream’s Air, with self service model and AI-enabled automation being a distinct

Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 10:20:00 EEST | Press release

Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P

Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 09:49:00 EEST | Press release

Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FDA validated Brenus Pharma's advanced regulatory and manufacturing capabilities. This operational readiness will accelerate patient access and data generation across both European and US sites for a Phase II program planned for 2027. "FDA's acceptance of our IND represents a major validation of our program and enables the full execution of our clinical strategy across Europe and the United States. Achieving regulatory alignment across multiple jurisdictions refl

Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 09:00:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare and specialty care where there is significant unmet patient need, presented positive results from the OLINGUITO Phase 3 clinical trial (NCT05785611iEudraCT 2022-501354-10-01ii) at EULAR 2026. In OLINGUITO filgotinib, an oral, once-daily JAK1 preferential inhibitor under investigation for the treatment of adult patients with active axial spondyloarthritis (axSpA), demonstrated sustained improvements in the signs and symptoms of axSpA, including disease activity and inflammation.iii Safety was consistent with the known profile of filgotinib, indicating a favourable benefit-risk profile for patients with active axSpA.iii The OLINGUITO trial consists of two international, randomised, double-blind, placebo-controlled studies (Study A and Study B), evaluating the efficacy and safety of filgotinib 200mg once-daily vs. placebo in patients with an established diagnosis of axSpA as per ASAS classification.i Eligi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye